Skip to main navigation Skip to search Skip to main content

ChromaDose: In-vitro diagnostic device development and validation, enabling point-of-care therapeutic drug monitoring for dose optimisation of anthracycline chemotherapy in paediatric cancer settings

Project Details

Short titleChromaDose: In-vitro diagnostic device development and validation, enabling point-of-care therapeutic drug monitoring for dose optimisation of anthracycline chemotherapy in paediatric cancer settings
StatusFinished
Effective start/end date1/01/21 → 30/12/23

Funding

  • NIHR